Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by corona… Recruiting

2024-514874-36-01 Refractory angina due to obstructive coronary artery di 2026-04-17
A Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with … Recruiting

2025-522407-23-00 Chronic kidney disease (CKD) and hypertension. 2026-04-16
Study to Assess the Ability of ONL1204 to Slow the Progression of Atrophic Age-related Macular Degeneration Recruiting

2024-513174-22-00 Atrophic Age-related Macular Degeneration (AMD) 2026-04-14
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma Recruiting

2025-524542-10-00 Endometrial cancer 2026-04-14
Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP) Recruiting

2025-524679-22-00 Maturity-onset diabetes of the young type 3 (HNF1A-MODY 2026-04-14
Therapeutic equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in subjects with mild to moderate asthma (TRECONY) Recruiting

2025-521456-35-00 Mild to moderate asthma 2026-04-13
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia Recruiting

2025-521868-35-00 Schizophrenia 2026-04-08
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose Comparison and Exploratory Efficacy Study of Orally Administered SAT-3247 in A… Recruiting

2025-522522-13-01 Duchenne muscular dystrophy 2026-04-08
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) Recruiting

2025-523743-35-00 Heart failure, cardiovascular disease, chronic kidney d 2026-04-07
Repurposing statins as adjuvants for cancer patients receiving therapy with immune checkpoint inhibitors: the STARK trial Recruiting

2024-518500-47-00 Non Small Cell Lung Cancer (NSCLC) 2026-04-07
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma Recruiting

2024-519208-29-00 Pleural mesothelioma 2026-04-02
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination with Atezolizumab… Recruiting

2024-517490-24-00 Small Cell Lung Cancer 2026-03-31
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study Recruiting

2025-522338-30-00 Ulcerative Colitis 2026-03-31
Is [18F]-DPA-714 PET a good marker of neuroinflammation in autoimmune encephalitis? (EAI-714) Recruiting

2025-522768-33-00 autoimmune encephalitis 2026-03-31
Local Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial Recruiting

2024-516544-26-00 acute ischemic stroke 2026-03-30
Pacritinib for Patients With Myelofibrosis Who Have Thrombocytopenia Recruiting

2025-522509-39-00 Patients with myelofibrosis and platelets counts betwee 2026-03-30
A study to learn if galvokimig is safe and works in adults with moderate to severe atopic dermatitis Recruiting

2025-522578-35-00 Atopic Dermatitis 2026-03-30
A phase II, randomized, open-label, national, multicenter study evaluating the efficacy and safety of the combination of atezolizumab and be… Recruiting

2025-521459-22-00 Patients with resectable hepatocellular carcinoma (amen 2026-03-27
CSX-1004 Effects on Fentanyl-Induced Respiratory Depression Recruiting

2025-524133-33-00 Opioid use disorder 2026-03-27
Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children with Sickle Cell Dis… Recruiting

2024-513750-30-00 Sickle Cell Disease 2026-03-25
Topical delgocitinib for facial vitiligo Recruiting

2025-523635-19-00 Vitiligo 2026-03-25
Developing a first-void urine-based infection model to assess HPV virion infectivity after vaccination. Recruiting

2025-522053-18-00 Human Papillomavirus infection 2026-03-25
DT-101 in Adults with Major Depressive Disorder Recruiting

2025-522784-15-00 Major Depressive Disorder 2026-03-24
Zanubritnib and anti-MAG neuropathy Recruiting

2025-523091-23-00 Peripheral anti-MAG neuropathy, waldenstrom macroglobul 2026-03-24